What did @christineabrahamm actually say?
Christine is not promoting Ozempic. She's venting. She's watching her social circle shrink in front of her, crediting semaglutide, while she's putting in hours at Pilates. The anxiety here is real and worth taking seriously. Her core claim is that friends are losing weight "overnight" on Ozempic while she grinds away at a studio. She also says this is damaging her body image, even though she says she has "never felt fat" in her life. That tension, between knowing something is irrational and still feeling it, is the emotional center of this video.
She's not making a clinical argument. But her framing of Ozempic as a rapid, effort-free solution that's producing dramatic visible results faster than exercise is an implicit claim, and that claim has some real problems with it.
Does the science back this up?
Not entirely. The "overnight" framing is wrong, but the overall weight loss is real and meaningful. Clinical trial data shows semaglutide (Wegovy) produces an average of about 15% body weight loss over 68 weeks, not days or weeks. The STEP 1 trial (Wilding et al., 2021, NEJM) found that participants lost a mean of 14.9% of body weight, but it took over a year of weekly injections.
What does happen quickly is appetite suppression. Some users report reduced hunger within the first one to two weeks of starting. That subjective experience, eating less almost immediately, can translate to visible weight changes within a month. But "toned arms" and dramatic body composition shifts? That takes time, and it takes muscle, which GLP-1 drugs don't build. In fact, research including data from the STEP trials suggests that a meaningful portion of weight lost on semaglutide, roughly 25-39%, is lean mass, not just fat (Bikou et al., 2024, Journal of Clinical Medicine). So her friends may look thinner without necessarily looking more toned.
What did they get wrong (or right)?
She got the social spread right. Semaglutide prescriptions have exploded, and it's genuinely saturating certain social networks, particularly among younger women. That observation is accurate.
What she got wrong is the implied comparison. She's measuring Pilates results against Ozempic results as if they're competing for the same goal. They're not. Pilates builds strength, posture, and neuromuscular control. Semaglutide reduces caloric intake by mimicking a gut hormone. Someone on Ozempic who isn't exercising may weigh less but have worse body composition than Christine does right now. The number on the scale is not the same as the outcome she says she wants: "I just want to be toned."
She's also conflating short-term visual results with long-term body image resolution. There is growing clinical concern about GLP-1 drugs and disordered eating patterns. A 2023 review (Garvey et al., Obesity Reviews) flagged that patients with a history of restrictive eating behaviors need careful screening before starting GLP-1 therapy. Christine's distress about comparison and body image is exactly the kind of psychological context that warrants a real conversation with a clinician, not a TikTok comment telling her Ozempic ruined someone's life.
What should you actually know?
GLP-1 receptor agonists like semaglutide are FDA-approved medications for chronic weight management and type 2 diabetes. They work by slowing gastric emptying and reducing appetite through hormone receptor activity. They are not a "hack." They require ongoing use, come with documented side effects including nausea, vomiting, and gastrointestinal distress, and weight tends to return when the medication is stopped, as shown in the STEP 4 withdrawal trial (Rubino et al., 2021, JAMA).
The body image piece Christine raises is clinically significant and underreported. Watching peers change their bodies rapidly through medication can trigger comparative distress even in people without a prior history of body dissatisfaction. That's not weakness. It's a documented psychological response to social norm shifts. If you're experiencing significant distress around body image, that conversation belongs with a therapist or psychiatrist, not in a TikTok comment section.
- Semaglutide is not appropriate for people who simply want to be "toned." It is a treatment for obesity or overweight with weight-related comorbidities.
- The "overnight" results people perceive socially are often months of gradual change compressed into a single comparison moment.
- Lean mass loss is a real concern with GLP-1 drugs. Resistance training is recommended alongside medication for this reason.
- Anyone considering a GLP-1 medication should discuss their full mental health history with a licensed provider, not just their weight history.